← brief for 2026-08-26 · Nutrition & lifestyle

A randomized controlled trial evaluating the impact of curcumin versus pentoxifylline on patients with chronic kidney disease

Paper B Peer reviewed Small trial

Key takeaways

This was a randomized trial comparing curcumin, the yellow compound in turmeric, with pentoxifylline, a drug that improves blood flow, in people with chronic kidney disease. Both were tested as add-ons to usual care. The size of the trial and how long it ran are not stated in what we received, which matters a lot for how much weight to give it. Curcumin is a supplement, and supplements can interact with kidney medicines, so this is a question for her nephrologist, not a reason to start taking it.

Who did this work

Nada M Kamel (Tanta University) · Ahmed ElKoraie (Alexandria University) · Tarek M. Mostafa (Tanta University) · Fedaa A. Kotkata (Tanta University)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-20
https://doi.org/10.1186/s43094-026-01012-8